It is a pharma private limited company based in Bhopal, Madhya Pradesh, India, established in 2018.
2018 | Bhopal, Madhya Pradesh, India | ActiveNexina Life Sciences Private Limited, a active private limited company, was established on 07 September 2018 in Bhopal, Madhya Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239MP2018PTC046490. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.40 M.
It upholds a compliant status. Employing 44 professional, Its leadership includes Nidhi Awasthi (Director), Yogendra Parashar (Director), Vanita Parashar (Managing Director). Past directors included Nidhi Awasthi, Yogendra Parashar, Shriram Garg. It holds ₹5.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at H.No.86 D K Honey Homes Kolar Road Nayapura, Bhopal, Madhya Pradesh, 462042.
U24239MP2018PTC046490
046490
07 September 2018
₹1.00 M
₹0.40 M
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Nexina Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nidhi Awasthi | Director | 04 Jan 2019 | Current |
| Yogendra Parashar | Director | 29 May 2021 | Current |
| Vanita Parashar | Managing Director | 07 Sep 2018 | Current |
| Rajni Kulhar | Director | 04 Jan 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 27 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 25 Nov 2021 | Past |
| Pramod Abcsdd | Director | 30 Jan 2024 | Past |
| Pramod Abcsdd | Additional Director | 27 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nexina Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 48.81% increase. The company also saw a substantial improvement in profitability, with a 89.07% increase in profit. The company's net worth observed a substantial decline by a decrease of 95.43%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Nexina Life Sciences had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹5,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Mar 2024 | Axis Bank Limited | ₹5.00 M | Open |
Explore comprehensive loan charge details -
Nexina Life Sciences has a workforce of 44 employees as of Jan 31, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Nexina Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nexina Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Nexina Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Nexina Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior. was recorded as a recent event.
A charge with Axis Bank Limited amounted to Rs. 5.00 M with Charge ID 100897877 was registered on 04 Mar 2024. was recorded as a recent event.
The activity Yogendra Parashar was appointed as a Director was appointed as a Director on 29 May 2021 & has been associated with this company since 4 years 6 months . was completed.
The activity Nidhi Awasthi was appointed as a Director was appointed as a Director on 04 Jan 2019 & has been associated with this company since 6 years 11 months . was completed.
Progress on Rajni Kulhar was appointed as a Director was appointed as a Director on 04 Jan 2019 & has been associated with this company since 6 years 11 months . was documented.
The CIN of Nexina Life Sciences Private Limited is U24239MP2018PTC046490.
Nexina Life Sciences Private Limited is headquartered at H.No.86 D K Honey Homes Kolar Road Nayapura, Bhopal, Madhya Pradesh, 462042.
Nexina Life Sciences Private Limited was incorporated on 07 September 2018.
The current directors of Nexina Life Sciences Private Limited are
The primary industry of Nexina Life Sciences Private Limited is Manufacturing.
Nexina Life Sciences Private Limited is unlisted.
The authorized capital of Nexina Life Sciences Private Limited is ₹1.00 M, and the paid-up capital is ₹0.40 M.
The compliance status of Nexina Life Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX